ArticleGlobal health research and policy2025
Enhancing the role of innovative financing in global health.
Article in Global health research and policy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Crimean-Congo Hemorrhagic Fever Virus in Africa: Epidemiological Trends, Transmission Ecology, Hotspot Heterogeneity, and Preparedness Challenges-A Narrative Review.Tropical medicine and infectious disease · 2026Review
- Impact of fracture table availability and usability on surgical decision-making: a national cross-sectional survey of Nigerian orthopaedic surgeons.International orthopaedics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Innovative financing mobilizes funds across varied channels using solidarity, Public-Private Partnerships and catalytic mechanisms to address unmet global health needs and engage investors as partners in development. As a supplementary measure to official development assistances (ODA), it offers a potential remedy for the current challenges in global health financing. Its significance has been magnified in the post-COVID era, where inadequate funding presents a significant hurdle to achieving Universal Health Coverage by 2030. Although efforts to promote innovative financing mechanisms have yielded some impactful results, existing bottlenecks hinder their widespread adoption and implementation. Collaboration among stakeholders is now imperative to foster the development and adoption of innovative financing tools in global health, necessitating the upgrading of existing methods and exploration of new avenues. We strongly advocate for engagement with the private sector, as it could revitalize investments in global health through the infusion of additional financial resources. The significance of innovation and the transformation of global health financing mechanisms also warrant attention. It is high time for all stakeholders to join forces and take actions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.